AMS:PHARM - NL0010391025 - Common Stock
TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
---|---|---|---|---|---|---|---|---|
CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
Net Income | 3.46M | -8.51M | -12.01M | 14.99M | 23.08M | |||
Depreciation Amortization | 15.73M | 16.07M | 15.93M | 13.19M | 19.61M | |||
Change In Working Capital | -10.77M | -20.45M | -14.73M | -1.54M | -4.91M | |||
Interest Paid | 6.59M | 5.60M | 4.05M | 3.95M | 4.45M | |||
Taxes Paid | 15.16M | 15.58M | 655.00K | 1.24M | 0.00 | |||
Other non cash items | 22.61M | 11.08M | -6.48M | -4.18M | 62.00K | |||
OPERATING CASH FLOW | 31.05M | -1.79M | -17.30M | 22.46M | 37.84M | |||
CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
Capital Expenditure | -918.00K | -796.00K | -1.46M | -1.98M | -16.72M | |||
Other Investing Activity | 22.12M | 32.41M | -127.92M | 7.30M | -4.59M | |||
INVESTING CASH FLOW | 21.21M | 31.62M | -129.39M | 5.32M | -21.30M | |||
CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
Debt Issued/Reduced | -3.96M | -34.39M | -5.13M | -3.31M | -3.22M | |||
Stock Issued/Repurchased | 3.40M | 5.58M | 8.13M | 2.28M | 4.72M | |||
Other Financing Activity | -12.56M | -5.60M | -4.05M | -3.95M | -29.45M | |||
FINANCING CASH FLOW | -13.11M | -34.41M | -1.04M | -4.98M | -27.95M | |||
Exchange Rate Effect | 5.81M | -2.21M | 2.13M | -7.38M | -1.82M | |||
CHANGE IN CASH | 44.95M | -6.80M | -145.60M | 15.42M | -13.23M | |||
FREE CASH FLOW | ||||||||
Operating Cash Flow | 31.05M | -1.79M | -17.30M | 22.46M | 37.84M | |||
Capital Expenditure | -918.00K | -796.00K | -1.46M | -1.98M | -16.72M | |||
FREE CASH FLOW | 30.13M | -2.59M | -18.77M | 20.48M | 21.13M |
All data in USD